REGENXBIO INC (RGNX) Stock Analyst Earnings Estimates
NASDAQ:RGNX - Nasdaq - US75901B1070 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 112.7M -76.04% | 90.242M -19.93% | 83.328M -7.66% | 355.88M 327.08% | 293.35M -17.57% | 332.91M 13.49% | 483.86M 45.34% | 674.23M 39.34% | 875.24M 29.81% | 1.026B 17.22% | 1.047B 2.05% | |
| EBITDA YoY % growth | -250M -247.41% | -250.808M -0.32% | -214.13M 14.62% | 24.651M 111.51% | -34.842M -241.34% | -62.475M -79.31% | -25.733M 58.81% | 97.215M 477.79% | 181.67M 86.87% | 193.05M 6.26% | 213.65M 10.67% | |
| EBIT YoY % growth | -262.9M -264.31% | -268.128M -1.99% | -230.345M 14.09% | 18.407M 107.99% | -126.958M -789.73% | -100.681M 20.70% | -70.573M 29.90% | 105.97M 250.16% | 299.97M 183.07% | 344.74M 14.92% | 357.59M 3.73% | |
| Operating Margin | -233.27% | -297.12% | -276.43% | 5.17% | -43.28% | -30.24% | -14.59% | 15.72% | 34.27% | 33.60% | 34.15% | |
| EPS YoY % growth | -6.50 -337.23% | -6.03 7.23% | -4.56 24.38% | -0.06 98.76% | -2.77 -4,791.11% | -2.76 0.38% | -1.98 28.15% | 0.45 122.88% | 3.70 715.73% | 10.14 173.83% | 9.79 -3.42% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.12 -6.86% | 0.40 134.55% | 0.31 130.30% | -0.52 -536.90% | -1.16 -3.18% | -1.19 -393.92% | -0.29 -195.00% |
| Revenue Q2Q % growth | 28.675M 28.62% | 112.22M 363.78% | 83.88M 295.40% | 65.543M -26.37% | 25.306M -11.75% | 26.836M -76.09% | 79.876M -4.77% |
| EBITDA Q2Q % growth | -59.955M -25.41% | 5.094M 110.21% | 69.227M 296.93% | 151.79M 843.85% | -50.847M 15.19% | -52.071M -1,122.20% | -49.878M -172.05% |
| EBIT Q2Q % growth | -37.457M 33.16% | 30.102M 148.49% | -209.437K 99.59% | -15.764M -229.99% | -71.859M -91.84% | -73.955M -345.68% | -24.092M -11,403.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.12 109.02% | 0.49 | -0.37 | -75.63% |
| Q4 2024 Q2Q % growth | -1.01 29.37% | -1.17 | 0.16 | 13.65% |
| Q3 2024 Q2Q % growth | -1.17 17.02% | -1.14 | -0.03 | -2.21% |
| Q2 2024 Q2Q % growth | -1.05 36.75% | -1.32 | 0.27 | 20.28% |
| Q1 2024 Q2Q % growth | -1.33 13.07% | -1.28 | -0.05 | -3.57% |
| Q4 2023 Q2Q % growth | -1.43 -3.62% | -1.30 | -0.13 | -10.34% |
| Q3 2023 Q2Q % growth | -1.41 19.43% | -1.55 | 0.14 | 8.92% |
| Q2 2023 Q2Q % growth | -1.66 -5.06% | -1.41 | -0.25 | -17.51% |
| Q1 2023 Q2Q % growth | -1.53 14.53% | -1.57 | 0.04 | 2.39% |
| Q4 2022 Q2Q % growth | -1.38 -120.69% | -1.26 | -0.12 | -9.61% |
| Q3 2022 Q2Q % growth | -1.75 -27.74% | -1.49 | -0.26 | -17.40% |
| Q2 2022 Q2Q % growth | -1.58 -16.18% | -1.56 | -0.02 | -1.43% |
| Q1 2022 Q2Q % growth | -1.79 -49.17% | -1.34 | -0.45 | -33.35% |
| Q4 2021 Q2Q % growth | 6.67 637.90% | 4.81 | 1.86 | 38.79% |
| Q3 2021 Q2Q % growth | -1.37 -418.60% | -1.10 | -0.27 | -24.56% |
| Q2 2021 Q2Q % growth | -1.36 -49.45% | -1.14 | -0.22 | -19.51% |
| Q1 2021 Q2Q % growth | -1.20 -11.11% | -1.31 | 0.11 | 8.29% |
| Q4 2020 Q2Q % growth | -1.24 -72.22% | -0.44 | -0.80 | -179.92% |
| Q3 2020 Q2Q % growth | 0.43 145.74% | -1.03 | 1.46 | 141.67% |
| Q2 2020 Q2Q % growth | -0.91 -2,175.00% | -0.90 | -0.01 | -0.69% |
| Q1 2020 Q2Q % growth | -1.08 -21.35% | -0.89 | -0.19 | -21.70% |
| Q4 2019 Q2Q % growth | -0.72 | -0.45 | -0.27 | -60.43% |
| Q3 2019 Q2Q % growth | -0.94 | -0.73 | -0.21 | -29.07% |
| Q2 2019 Q2Q % growth | -0.04 | -0.62 | 0.58 | 93.59% |
| Q1 2019 Q2Q % growth | -0.89 | -0.88 | -0.01 | -1.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 89.012M 469.79% | 104.01M | -14.998M | -14.42% |
| Q4 2024 Q2Q % growth | 21.214M -4.50% | 24.229M | -3.015M | -12.44% |
| Q3 2024 Q2Q % growth | 24.197M -16.31% | 24.06M | 137K | 0.57% |
| Q2 2024 Q2Q % growth | 22.295M 11.60% | 23.432M | -1.137M | -4.85% |
| Q1 2024 Q2Q % growth | 15.622M -18.37% | 23.995M | -8.373M | -34.89% |
| Q4 2023 Q2Q % growth | 22.213M -29.03% | 34.679M | -12.466M | -35.95% |
| Q3 2023 Q2Q % growth | 28.914M 9.11% | 26.687M | 2.227M | 8.34% |
| Q2 2023 Q2Q % growth | 19.977M -38.72% | 35.195M | -15.218M | -43.24% |
| Q1 2023 Q2Q % growth | 19.138M -13.79% | 31.208M | -12.07M | -38.68% |
| Q4 2022 Q2Q % growth | 31.3M -92.15% | 38.2M | -6.9M | -18.06% |
| Q3 2022 Q2Q % growth | 26.5M -13.96% | 31.428M | -4.928M | -15.68% |
| Q2 2022 Q2Q % growth | 32.6M 48.18% | 27.322M | 5.278M | 19.32% |
| Q1 2022 Q2Q % growth | 22.2M 17.46% | 29.792M | -7.592M | -25.48% |
| Q4 2021 Q2Q % growth | 398.7M 1,763.08% | 277.17M | 121.53M | 43.85% |
| Q3 2021 Q2Q % growth | 30.8M -68.86% | 42.294M | -11.494M | -27.18% |
| Q2 2021 Q2Q % growth | 22M 32.53% | 29.603M | -7.603M | -25.68% |
| Q1 2021 Q2Q % growth | 18.9M 7.39% | 23.697M | -4.797M | -20.24% |
| Q4 2020 Q2Q % growth | 21.4M 81.36% | 62.733M | -41.333M | -65.89% |
| Q3 2020 Q2Q % growth | 98.9M 572.79% | 21.793M | 77.107M | 353.82% |
| Q2 2020 Q2Q % growth | 16.6M 110.13% | 22.511M | -5.911M | -26.26% |
| Q1 2020 Q2Q % growth | 17.6M 1,855.56% | 18.819M | -1.219M | -6.48% |
| Q4 2019 Q2Q % growth | 11.8M | 40.463M | -28.663M | -70.84% |
| Q3 2019 Q2Q % growth | 14.7M | 10.747M | 3.953M | 36.78% |
| Q2 2019 Q2Q % growth | 7.9M | 17.316M | -9.416M | -54.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -16.8% | -11.12% | 88.58% |
| Revenue | 0% | -21.26% | 0% | 10.89% |